These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2436995)
21. [Factor XIII-heparin complex and its properties as a physiological solvent for unstabilized fibrin]. Ul'ianov AM; Kudriashov BA Vopr Med Khim; 1975; 21(1):19-23. PubMed ID: 235172 [TBL] [Abstract][Full Text] [Related]
22. Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders. Alkjaersig N; Fletcher AP; Lewis M; Ittyerah R Thromb Haemost; 1977 Dec; 38(4):863-73. PubMed ID: 579691 [TBL] [Abstract][Full Text] [Related]
23. Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin). Mismetti P; Laporte-Simitsidis S; Navarro C; Sié P; d'Azemar P; Necciari J; Duret JP; Gaud C; Decousus H; Boneu B Thromb Haemost; 1998 Jun; 79(6):1162-5. PubMed ID: 9657442 [TBL] [Abstract][Full Text] [Related]
24. Immobilization of factor XIII on collagen membranes. Blanchy BG; Coulet PR; Gautheron DC J Biomed Mater Res; 1986 Apr; 20(4):469-79. PubMed ID: 3700441 [TBL] [Abstract][Full Text] [Related]
25. A microtiter plate assay for factor XIII A-chain-fibrin interactions. Achyuthan KE; Santiago MA; Greenberg CS Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954 [TBL] [Abstract][Full Text] [Related]
26. [Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?]. Korte W; Corbetta C; Schmid L Schweiz Med Wochenschr; 1995 Mar; 125(9):420-3. PubMed ID: 7892570 [TBL] [Abstract][Full Text] [Related]
27. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study]. Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488 [TBL] [Abstract][Full Text] [Related]
28. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
29. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease. Lynch GW; Pfueller SL Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573 [TBL] [Abstract][Full Text] [Related]
30. Identification of intracellular factor XIII in human monocytes and macrophages. Henriksson P; Becker S; Lynch G; McDonagh J J Clin Invest; 1985 Aug; 76(2):528-34. PubMed ID: 2863285 [TBL] [Abstract][Full Text] [Related]
31. Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role? Prenzel F; Pfäffle R; Thiele F; Schuster V Klin Padiatr; 2006; 218(3):174-6. PubMed ID: 16688675 [TBL] [Abstract][Full Text] [Related]
32. Therapy of deep vein thrombosis. Turpie AG Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442 [TBL] [Abstract][Full Text] [Related]
33. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385 [TBL] [Abstract][Full Text] [Related]
34. Fibrin cross-linking in congenital factor XIII deficiency. Rodeghiero F; Barbui T J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341 [TBL] [Abstract][Full Text] [Related]
35. Factor XIII assay by an isotope method. II. Heparin inhibition of factor XIII activation. Dvilansky A; Britten AF; Loewy AG Thromb Diath Haemorrh; 1970 Oct; 24(1):256-64. PubMed ID: 5483966 [No Abstract] [Full Text] [Related]
36. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery. Speziale F; Verardi S; Taurino M; Nicolini G; Rizzo L; Fiorani P; Palazzini E Pharmatherapeutica; 1988; 5(4):261-8. PubMed ID: 3174726 [TBL] [Abstract][Full Text] [Related]
37. Intracellular factor XIII: cellular distribution of factor XIII subunit a in humans. Adány R Semin Thromb Hemost; 1996; 22(5):399-408. PubMed ID: 8989823 [TBL] [Abstract][Full Text] [Related]
38. Factor XIII: enzymatic and clinical aspects. Karges HE; Clemens R Behring Inst Mitt; 1988 Apr; (82):43-58. PubMed ID: 3044345 [TBL] [Abstract][Full Text] [Related]
39. Factor XIII Deficiency. Karimi M; Bereczky Z; Cohan N; Muszbek L Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071 [TBL] [Abstract][Full Text] [Related]
40. Factor XIII of blood coagulation in human monocytes. Muszbek L; Adány R; Szegedi G; Polgár J; Kávai M Thromb Res; 1985 Feb; 37(3):401-10. PubMed ID: 2859670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]